1: Applications in Cancers and Immunological Diseases / editors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol |
Pubbl/distr/stampa | Cham, : Springer, 2021 |
Descrizione fisica | XIV, 367 p. : ill. ; 24 cm |
Disciplina |
616.079(Immunologia)
660.6(Biotecnologia. Microbiologia applicata) 615.1(Farmacologia. Farmaci. Farmacia) 610.28(Ingegneria biomedica) |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN0243959 |
Cham, : Springer, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
1: Applications in Cancers and Immunological Diseases / editors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol |
Pubbl/distr/stampa | Cham, : Springer, 2021 |
Descrizione fisica | XIV, 367 p. : ill. ; 24 cm |
Disciplina |
616.079(Immunologia)
660.6(Biotecnologia. Microbiologia applicata) 615.1(Farmacologia. Farmaci. Farmacia) 610.28(Ingegneria biomedica) |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN00243959 |
Cham, : Springer, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
3: Probiotics and Gut Skin Axis–Inside Out and Outside In / editors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol |
Pubbl/distr/stampa | Cham, : Springer, 2021 |
Descrizione fisica | XIV, 293 p. : ill. ; 24 cm |
Disciplina |
616.079(Immunologia)
660.6(Biotecnologia. Microbiologia applicata) 615.1(Farmacologia. Farmaci. Farmacia) 610.28(Ingegneria biomedica) |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN0260851 |
Cham, : Springer, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
3: Probiotics and Gut Skin Axis–Inside Out and Outside In / editors Indu Pal Kaur (Editor-in-Chief), Parneet Kaur Deol |
Pubbl/distr/stampa | Cham, : Springer, 2021 |
Descrizione fisica | XIV, 293 p. : ill. ; 24 cm |
Disciplina |
616.079(Immunologia)
660.6(Biotecnologia. Microbiologia applicata) 615.1(Farmacologia. Farmaci. Farmacia) 610.28(Ingegneria biomedica) |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNICAMPANIA-VAN00260851 |
Cham, : Springer, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Vanvitelli | ||
|
Acute Phase Proteins : Regulation and Functions of Acute Phase Proteins / / Sabina Janciauskiene, editor |
Autore | Francisco Veas |
Pubbl/distr/stampa | IntechOpen, 2011 |
Descrizione fisica | 1 online resource (190 pages) : illustrations |
Disciplina | 616.079 |
Soggetto topico | Immunology |
Soggetto non controllato |
Medicine
Immunology Immunoproteomics Allergology and Rheumatology Health Sciences |
ISBN | 953-51-4424-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Acute phase proteins |
Record Nr. | UNINA-9910138291103321 |
Francisco Veas
![]() |
||
IntechOpen, 2011 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Advanced Concepts in Human Immunology: Prospects for Disease Control / / edited by Pooja Jain, Lishomwa C. Ndhlovu |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 |
Descrizione fisica | 1 online resource (XVIII, 403 p. 16 illus., 5 illus. in color.) |
Disciplina | 616.079 |
Soggetto topico |
Immunology
Vaccines Infectious diseases Cancer - Research Immunologia Sistema immunitari Malalties autoimmunitàries Càncer Al·lèrgia Malalties neurodegeneratives Malalties infeccioses Vaccine Infectious Diseases Cancer Research |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-33946-7 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Human Chronic Viruses: Pathogenesis, host response, and treatment -- 2. Defining the Role of Immunoproteomics in Human Immunotherapy -- 3. Microbiome and Cellular Players in Type 1 Diabetes: from Pathogenesis to Protection -- 4. Immune Mechanisms, Pathology, and Management of Allergic Ocular Diseases -- 5. Dendritic Cell-regulated T Cell Immunity and Tolerance against Acute Myeloid Leukemia -- 6. Perspectives on the Role of T cell Negative Immune Checkpoint Receptors in Health and Disease -- 7. Neuroprotective Immunity for Neurodegenerative and Neuroinfectious Diseases -- 8. Polycystic Ovary Syndrome: An overview of a complex, heterogeneous genetic condition. |
Record Nr. | UNINA-9910416101503321 |
Cham : , : Springer International Publishing : , : Imprint : Springer, , 2020 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Advanced immunochemistry / Eugene D. Day |
Autore | Day, Eugene D. |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | New York [etc] : Wiley-LISS, c 1990 |
Descrizione fisica | xxiii, 693 p. : ill. ; 25 cm |
Disciplina | 616.079 |
Soggetto topico | Immunologia |
ISBN | 047156768X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNISALENTO-991003061369707536 |
Day, Eugene D.
![]() |
||
New York [etc] : Wiley-LISS, c 1990 | ||
![]() | ||
Lo trovi qui: Univ. del Salento | ||
|
Advances immunochemistry / Eugene D. Day |
Autore | Day, Eugene D. |
Edizione | [2nd ed.] |
Pubbl/distr/stampa | New York : Wiley-Liss, 1990 |
Descrizione fisica | XXII, 693 p. ; 25 cm |
Disciplina | 616.079 |
Soggetto non controllato | Immunologia |
ISBN | 0-471-56768-X |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-990001750630403321 |
Day, Eugene D.
![]() |
||
New York : Wiley-Liss, 1990 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Advances in clinical immunology : the role of chemical mediators in pulmonary and cardiac diseases / edited by M. Condorelli, G. Marone, L. M. Lichtenstein |
Pubbl/distr/stampa | Firenze : O.I.C. Medical Press, 1984 |
Descrizione fisica | 254 p. ; 25 cm |
Disciplina | 616.079 |
Soggetto non controllato | Immunopatologia |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | ita |
Record Nr. | UNINA-990002408260403321 |
Firenze : O.I.C. Medical Press, 1984 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Advances in host-directed therapies against tuberculosis / / Petros C. Karakousis, Richard Hafner, Maria Laura Gennaro, editors |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (XIII, 332 p. 20 illus.) |
Disciplina | 616.079 |
Soggetto topico | Immunotherapy |
ISBN | 3-030-56905-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Section 1: Introduction -- Chapter 1: Introduction: An overview of host-directed therapies for tuberculosis -- Section 2: Targeting immunometabolism -- Chapter 2: Sirtuin deacetylases: Linking Mycobacterial infection and host metabolism -- Chapter 3:The mammalian target of rapamycin complex 1 (mTORC1): an ally of M. tuberculosis in host cells -- Chapter 4: HIF-1α as a potential therapeutic target for tuberculosis treatment -- Chapter 5: Nuclear receptors in host-directed therapies against tuberculosis -- Section 3: Enhancing anti-mycobacterial mechanisms -- Chapter 6: Autophagy as a target for host-directed therapy against tuberculosis -- Chapter 7: Metformin: a leading HDT candidate for TB -- Chapter 8: Statins as host-directed therapy for tuberculosis -- Chapter 9: Antimycobacterial attributes of mitochondria: An insight into host defense mechanisms -- Section 4: Targeting immune cells -- Chapter 10: Conventional and unconventional lymphocytes in immunity against Mycobacterium tuberculosis -- Chapter 11: Targeting inhibitory cells such as Tregs and MDSCs in the tuberculous granuloma -- Chapter 12: Targeting suppressor T cells -- Chapter 13: Neutrophil-mediated mechanisms as targets for host-directed therapies against tuberculosis -- Chapter 14: Type I interferon and interleukin-1 driven inflammatory pathways as targets for HDT in tuberculosis -- Chapter 15: Mucosal-associated invariant and Vγ9Vδ2 T cells -- Chapter 16: Airway epithelial cells.-Section 5: Preclinical models for assessing HDTs -- Chapter 17: In vitro models of human granuloma formation to analyze host-directed therapies -- Chapter 18: C3HeB/FeJ as a key mouse strain for testing host-directed therapies against tuberculosis -- Chapter 19: The Rabbit Model for Assessing Host-Directed Therapies for Tuberculosis -- Section 6: Clinical trials of HDTs and special considerations for study endpoints -- Chapter 20:Clinical trials of TB-HDT candidates -- Chapter 21:Outcomes for clinical trials of host-directed therapies for tuberculosis -- Chapter 22: Pharmacological considerations for clinical trials of host-directed therapies for tuberculosis. |
Record Nr. | UNINA-9910484717803321 |
Cham, Switzerland : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|